Transcriptomics

Dataset Information

0

Monocytes in Type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression


ABSTRACT: Monocytes are immune regulators implicated in the pathogenesis of Type 1 diabetes (T1D), an autoimmune disease that targets the insulin-producing pancreatic β-cell. We determined that monocytes of recent onset (RO) T1D patients and their healthy siblings express proinflammatory/cytolytic transcriptomes and hyper-secrete cytokines in response to lipopolysaccharide exposure compared to unrelated healthy controls (uHC). Flow cytometry measured elevated circulating abundances of intermediate monocytes and >2-fold more CD14+CD16+HLADR+KLRD1+PRF1+ NK-like monocytes among ROT1D patients compared to uHC. The intermediate to nonclassical monocyte ratio among ROT1D patients correlated with the decline in functional β-cell mass during the first 24 months post-onset. Among sibling non-progressors, flow cytometry measured temporal decreases in the intermediate to nonclassical monocyte ratio and NK-like monocyte abundances; these changes coincided with increases in peripheral activated regulatory T-cells. In contrast, these monocyte populations exhibited stability among T1D progressors. This study associates heightened monocyte proinflammatory/cytolytic activity with T1D susceptibility and progression and offers insight to the age-dependent decline in T1D susceptibility.

ORGANISM(S): Homo sapiens

PROVIDER: GSE232310 | GEO | 2024/01/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-01 | GSE239501 | GEO
2011-05-01 | E-GEOD-25913 | biostudies-arrayexpress
2011-05-01 | GSE25913 | GEO
2015-10-07 | GSE73788 | GEO
2017-05-10 | GSE98717 | GEO
2020-03-06 | GSE146447 | GEO
2021-06-23 | GSE176290 | GEO
2024-10-30 | GSE249639 | GEO
2021-04-12 | GSE171862 | GEO
2015-06-27 | E-GEOD-70327 | biostudies-arrayexpress